From January 2010 to August 2013, 1797 FFPE tumor samples, derived from patients with mCRC, mMEL and NSCLC were selected to detect K-RAS, BRAF and EGFR somatic mutations, respectively. This evidence concerns the gene BRAF and non-small cell lung carcinoma.